These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35601411)

  • 21. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
    Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
    J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.
    Zhang Y; Bao XY; Duan L; Yang WZ; Li DS; Zhang ZS; Han C; Zhao F; Zhang Q; Wang QN
    J Neurosurg Pediatr; 2018 Aug; 22(2):173-180. PubMed ID: 29856299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of pro-thrombotic conditions in adult patients with moyamoya disease and moyamoya syndrome: a single center study.
    Larson A; Rinaldo L; Lanzino G; Klaas JP
    Acta Neurochir (Wien); 2020 Aug; 162(8):1853-1859. PubMed ID: 32462312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct versus indirect bypasses for adult ischemic-type moyamoya disease: a propensity score-matched analysis.
    Deng X; Gao F; Zhang D; Zhang Y; Wang R; Wang S; Cao Y; Zhao Y; Pan Y; Liu X; Zhang Q; Zhao J
    J Neurosurg; 2018 Jun; 128(6):1785-1791. PubMed ID: 28799875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient Ischemic Attack in Pediatric Patients With Moyamoya Disease: Clinical Features, Natural History, and Predictors of Stroke.
    Zhao M; Zhang D; Wang S; Zhang Y; Wang R; Zhao J
    Pediatr Neurol; 2017 Oct; 75():48-54. PubMed ID: 28778481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurosurgical management of proton beam therapy-induced moyamoya syndrome.
    Zhang CH; Muirhead W; Silva AHD; Toolis C; Robertson F; Rennie A; Bhate S; Thompson DNP; Ganesan V; James G
    J Neurosurg Pediatr; 2023 Apr; 31(4):369-379. PubMed ID: 36738468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down syndrome and moyamoya: clinical presentation and surgical management.
    See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
    J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of Moyamoya Syndrome in Pediatric Patients With Neurofibromatosis Type 1.
    Brosius SN; Vossough A; Fisher MJ; Lang SS; Beslow LA; George BJ; Ichord R
    Pediatr Neurol; 2022 Sep; 134():85-92. PubMed ID: 35849956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial phenotypes in moyamoya disease: a comparative analysis of clinical presentation and natural history in a single multiethnic cohort of 250 hemispheres.
    Feghali J; Xu R; Yang W; Liew J; Tamargo RJ; Marsh EB; Huang J
    J Neurosurg; 2020 Dec; 133(6):1766-1772. PubMed ID: 31585430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contralateral acute vascular occlusion following revascularization surgery for moyamoya disease.
    Sussman ES; Madhugiri V; Teo M; Nielsen TH; Furtado SV; Pendharkar AV; Ho AL; Esparza R; Azad TD; Zhang M; Steinberg GK
    J Neurosurg; 2019 Dec; 131(6):1702-1708. PubMed ID: 30554188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
    Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failures in Revascularization for Pediatric Moyamoya Disease and Syndrome: A Scoping Review.
    Shlobin NA; Frankel HG; Lam S
    World Neurosurg; 2021 May; 149():204-214.e1. PubMed ID: 33618047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study.
    Aldana PR; Hanel RA; Piatt J; Han SH; Bansal MM; Schultz C; Gauger C; Pederson JM; Iii JCW; Hulbert ML; Jordan LC; Qureshi A; Garrity K; Robert AP; Hatem A; Stein J; Beydler E; Adelson PD; Greene S; Grabb P; Johnston J; Lang SS; Leonard J; Magge SN; Scott A; Shah S; Smith ER; Smith J; Strahle J; Vadivelu S; Webb J; Wrubel D
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30336. PubMed ID: 37057741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
    Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
    World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When and why is surgical revascularization indicated for the treatment of moyamoya syndrome in patients with RASopathies? A systematic review of the literature and a single institute experience.
    Scala M; Fiaschi P; Capra V; Garrè ML; Tortora D; Ravegnani M; Pavanello M
    Childs Nerv Syst; 2018 Jul; 34(7):1311-1323. PubMed ID: 29797062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Management of Moyamoya Patients.
    Canavero I; Vetrano IG; Zedde M; Pascarella R; Gatti L; Acerbi F; Nava S; Ferroli P; Parati EA; Bersano A
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
    Pandey P; Steinberg GK
    J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posterior cerebral artery stenosis and posterior circulation revascularization surgery in pediatric patients with moyamoya disease.
    Kimiwada T; Hayashi T; Shirane R; Tominaga T
    J Neurosurg Pediatr; 2018 Jun; 21(6):632-638. PubMed ID: 29624146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study.
    Deng X; Gao F; Zhang D; Zhang Y; Wang R; Wang S; Cao Y; Zhao Y; Pan Y; Ye X; Liu X; Zhang Q; Wang J; Yang Z; Zhao M; Zhao J
    J Neurosurg; 2018 May; 128(5):1327-1337. PubMed ID: 28686113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
    Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
    J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.